Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.
$47.65M
Dr. Laxminarayan Bhat Ph.D.
5.00
Cupertino, CA
Oct 18, 2018
-1.09
$-1.32
1.21
1.29
0.00%
-3.26
0.01
61.72
0.00
1.21
-259.07%
-306.16%
Similar stocks (13)
ACADIA Pharmaceuticals Inc.
ACAD
EyePoint Pharmaceuticals, Inc.
EYPT
Cabaletta Bio, Inc.
CABA
Protalix BioTherapeutics, Inc.
PLX
SELLAS Life Sciences Group, Inc.
SLS
Lantern Pharma Inc.
LTRN
Fortress Biotech, Inc.
FBIO
Unicycive Therapeutics, Inc.
UNCY
Ocuphire Pharma, Inc.
OCUP
Cue Biopharma, Inc.
CUE
Athira Pharma, Inc.
ATHA
IN8bio, Inc.
INAB
Kiromic BioPharma, Inc.
KRBP
ETF Exposure (9)
iShares Micro-Cap ETF
IWC
0.00626%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
ACADIA Pharmaceuticals Inc.
ACAD
EyePoint Pharmaceuticals, Inc.
EYPT
Cabaletta Bio, Inc.
CABA
Protalix BioTherapeutics, Inc.
PLX
SELLAS Life Sciences Group, Inc.
SLS
Lantern Pharma Inc.
LTRN
Fortress Biotech, Inc.
FBIO
Unicycive Therapeutics, Inc.
UNCY
Ocuphire Pharma, Inc.
OCUP
Cue Biopharma, Inc.
CUE
Athira Pharma, Inc.
ATHA
IN8bio, Inc.
INAB
Kiromic BioPharma, Inc.
KRBP
ETF Exposure (9)
iShares Micro-Cap ETF
IWC
0.00626%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%